Pharma & Bio
Technology
A-Sleep Partners with Hyundai Engineering & Construction and Samsung Electronics on 'Sleep Orchestra'… "We Will Create a Wall Pad for the Bedroom"
A-Sleep is partnering with Hyundai Engineering & Construction, Samsung Electronics, and others to fully launch its “Sleep Orchestra” business, which automatically controls the bedroom environment. The…
Lifestyle
GI Innovation and G2G Bio Jump 20% on Hopes for a Licensing Deal [K-bio pulse]
The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
Lifestyle
G.I. Innovation and G2G Rise 20% on Expectations of Technology Exports [Bio Spotlight]
On the 1st, the KRX Healthcare Index rose 4.53% compared to the previous trading day, bringing a rare breath of fresh air to the pharmaceutical and biotech industry. Amid this, GI Innovation Inc.(3585…
Technology
[Caregen Co.,LTD. Deep Dive ①] The Truth Behind Caregen Co.,LTD.’s “Hundreds of Billions of Won Contract”… A 240 Billion Won Contract with a 9-Year Fulfillment Rate of 1.2%
Caregen Co.,LTD.(214370)has recently announced a series of overseas supply contracts worth hundreds of billions of won. However, given that many of its past major supply contracts ended with low fulfi…
Lifestyle
"Typhoid: 20 billion... Meningococcal: 100 billion"... EuBiologics Co., Ltd. Kicks Off Its "Post-Cholera Cash Cow" Initiative
EuBiologics Co., Ltd.(206650)is accelerating efforts to secure new revenue streams, led by its typhoid and meningococcal vaccines.
EuBiologics Co., Ltd.’s strategy to expand its vaccine portfolio. …
Technology
Competitor Drug Faces Challenges in Confirmatory Clinical Trials, HLB INC.’s Ripictu Receives Full Approval… Background on the FDA’s Decision
Few people know the U.S. Food and Drug Administration (FDA) approval process for “Ripicto” (generic name: lirapugratinib) as thoroughly as Jang Seong-hun, former vice president of Eleva Therapeutics. …
Lifestyle
[Exclusive] Remedy Selects Indonesia as Its Southeast Asian Hub… Sets Out to Establish a Local Production System
#Remedy, a company specializing in medical imaging and artificial intelligence (AI), has designated Indonesia as its key strategic base for targeting the Southeast Asian public healthcare market. The …
Technology
Helixmith and Genome & Company Surge on Royalty News [K-bio pulse]
Korean pharmaceutical, biotech, and healthcare stocks linked to drug commercialization and licensing prospects rallied on September 30.Helixmith rose nearly 20% on expectations of royalties from its C…
Technology
[Bio Spotlight] Gaining Momentum from 'Royalties, Technology Transfers, and Exclusive Rights'… Helixmith Co., Ltd and Genome&Company Soar
On the 30th, Helixmith Co., Ltd(084990)rose nearly 20% on expectations of royalties from the commercialization of a gene therapy by its Chinese partner, while Genome&Company(314130)posted double-digit…
Technology
Peptron, Inc.: Two Years Waiting for Lilly’s Response… Anticipation for Follow-up DDS Contract and Clinical Trial Announcements [Bio Monthly Roundup]
In October, the focus of the domestic pharmaceutical and biotech market is expected to shift to follow-up contracts by drug delivery system (DDS) companies and clinical results to be presented at glob…